Partnering between Large Pharmas - Does it Make Sense?
By Business Review Editor
PharmaDeals Review: Vol 2007 Issue 88 (Table of Contents)
Published: 7 Oct-2007
DOI: 10.3833/pdr.v2007i88.281 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
Abbott considers the deal with Genentech as a sensible move to bring its Phase I oncology products to market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
RSS